Remove Data Remove Reference Remove Safety
article thumbnail

Australia Cannabis Q&A

Canna Law Blog

Comply with relevant workplace health and safety legislation. Yesespecially in safety-sensitive industries (mining, transport, healthcare). Employers must balance workplace safety with disability discrimination laws. How should businesses handle cannabis-related workplace safety concerns? Data Privacy 29.

article thumbnail

The STATES Act Reintroduced: Bipartisan Measure Limits Federal Government’s Ability To Interfere With State-Sanctioned Marijuana Business, Policies

NORML

HR 1455 : The REFER Act (Restraining Excessive Federal Enforcement & Regulations of Cannabis Act), introduced by Congresswoman Barbara Lee (D-CA). Sixty-eight percent of registered voters “support the legalization of marijuana,” according to 2018 national polling data compiled by the Center for American Progress.

Policy 185
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

MyMD Pharmaceuticals Announces New Data from Comparative Study on Lead Compound MYMD-1

Cannabis Law Report

New data shows MYMD-1 has key differentiators and capabilities compared to existing TNF inhibitor drugs. Data also demonstrated that none of the biological drugs selected for the comparison study proved to be anti-proliferative to any of the primary cell types assessed. BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc.

article thumbnail

The FDA Issues Hemp-CBD Warning Letters and a Consumer Update

Canna Law Blog

In addition, the FDA reiterates its view that Hemp-CBD cannot be added to food or dietary supplements and states that it “cannot conclude that CBD is generally recognized as safe (GRAS) among qualified experts for its use in human or animal food” based on the available data. Consumer Update. Conclusion.

Hemp 145
article thumbnail

CBD Regulations Might Come Sooner than Expected

Canna Law Blog

Abernethy went on to explain that while the agency is enthusiastic about research into the therapeutic values of CBD-infused products, it is also concerned with the need for safety. Now that the public comment period is over, the FDA will review the submitted data and anticipates reporting on its progress “around end of summer/early fall.”.

CBD 99
article thumbnail

Report: Efficacy and safety of medical cannabinoids in children: a systematic review and meta-analysis

Cannabis Law Report

Despite the increased use of medical cannabinoids, the efficacy and safety of the treatment among children remain uncertain. The objective was to study the efficacy and safety of medical cannabinoids in children. Systematic review and meta-analysis were performed to examine the efficacy and safety of MCs treatment among children.

Safety 52
article thumbnail

New- ANH-Intl Special Report: Is safety the new gremlin for CBD regulation?

Cannabis Law Report

We take a look at where CBD regulation might be going and whether we should be concerned about safety writes Rob Verkerk PhD, scientific and executive director, ANH-Intl. We take a look at where CBD regulation might be going and whether we should be concerned about safety. A new ‘problem’: safety. ? A new ‘problem’: safety.

Safety 59